Cargando…
The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening
Tyrosinemia type I (TT1) is an inborn error of tyrosine metabolism with features including liver dysfunction, cirrhosis, and hepatocellular carcinoma; renal dysfunction that may lead to failure to thrive and bone disease; and porphyric crises. Once fatal in most infantile-onset cases, pre-symptomati...
Autores principales: | Priestley, Jessica R. C., Alharbi, Hana, Callahan, Katharine Press, Guzman, Herodes, Payan-Walters, Irma, Smith, Ligia, Ficicioglu, Can, Ganetzky, Rebecca D., Ahrens-Nicklas, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422996/ https://www.ncbi.nlm.nih.gov/pubmed/32832707 http://dx.doi.org/10.3390/ijns6020039 |
Ejemplares similares
-
Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts
Publicado: (1985) -
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma
por: Blackburn, Patrick R., et al.
Publicado: (2016) -
Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy
por: Stinton, Chris, et al.
Publicado: (2017) -
Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
por: Sethuram, Swathi, et al.
Publicado: (2021) -
Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretion
por: Jack, Rhona M., et al.
Publicado: (2019)